Paul Hastings, Chairman & CEO, Director at OncoMed Pharma, holds 390.51K shares in Nkarta (Ticker: NKTX), holds 8.37K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 346.87K shares in OncoMed Pharma (Ticker: OMED). Most recently, Paul Hastings Sold ― shares of Nkarta on Jan 18, 2024 for an estimated value of 84.75K.